ResearcherNippon Medical SchoolActive in the last 2 years
Ryuji Ohashi
Matched on ORCID iD 0000-0001-7053-038X; OpenAlex author ID A5059029488. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2024: 1 paper · 2025: none · 2026: 1 paper
Papers 2
- Cancer‑associated fibroblast‑derived extracellular vesicles promote pancreatic cancer progression via the RAP1B/ANLN axis. Last author DOI 10.3892/or.2026.9182↗
- Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using multi-omics analysis. Co-author DOI 10.1111/cas.16302↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Akira Matsushita · 2 shared papers, 2024–2026 · strength 0.44
- Paper Cancer‑associated fibroblast‑derived extracellular vesicles promote pancreatic cancer progression via the RAP1B/ANLN ax… DOI 10.3892/or.2026.9182↗
- Paper Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using mu… DOI 10.1111/cas.16302↗
- Junji Ueda · 1 shared paper, 2026 · strength 0.23
- Hiroshi Yoshida · 1 shared paper, 2026 · strength 0.23
- Kousuke Ishino · 1 shared paper, 2026 · strength 0.23
- Daigo Yoshimori · 1 shared paper, 2026 · strength 0.23
- Atsushi Masamune · 1 shared paper, 2026 · strength 0.23
- Tomoaki Toyoda · 1 shared paper, 2024 · strength 0.21
- Shingo Kato · 1 shared paper, 2024 · strength 0.21
- Kazufumi Honda · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.